HARTE-HANKS INC HHS
ASignal's systematic analysis rates HHS as Bearish.
Reflects the latest available analysis · analyzed Nov 9, 2026
The case on HHS
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Free cash flow is positive at $4.51M, indicating some cash generation ability
- Price near 20-day moving average with slight positive momentum (0.0101)
- MACD histogram is slightly expanding, suggesting weakening bearish momentum
- Forward P/E of 3.74x is low relative to growth expectations
- Negative operating margin (-12.17%) and negative ROE (-30.41%) indicate poor profitability and capital inefficiency
- High debt-to-equity ratio of 1.57x raises financial risk concerns
- EV/EBITDA of -121.22x suggests severe earnings deterioration or negative EBITDA
- Revenue growth YoY is negative at -1.70%
- No news coverage or Reddit mentions, indicating lack of market interest or information scarcity
See the full verdict on HHS
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes HHS
Most investors never get a second opinion, let alone several. ASignal runs HHS past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.